Skip to main content

Table 3 Demographic and clinical factors for patients by depression symptom outcome at 6-monthsa

From: Factors associated with response and remission from depression at 6-months of treatment in a retrospective cohort treated within an integrated care program

  PHQ-9 < 5 PHQ-9 ≥ 5   PHQ-9 < 10 PHQ-9 ≥ 10   Δ PHQ-9 ≥ 6 Δ PHQ-9 < 6  
Nb (%c)
Baseline PHQ-9
 Total Score, Mean (SD) 13.94 (3.95) 16.25 (4.58) **d 14.44 (4.08) 17.14 (4.60) ** 16.61 (4.57) 15.26 (4.47) **
 Item 9e 25 (25.00) 223 (43.30) ** 91 (31.49) 157 (48.16) ** 114 (41.16) 134 (39.64)  
Gender
 Male 32 (32.00) 179 (34.76)   103 (35.64) 108 (33.13)   98 (35.38) 113 (33.43)  
 Female 68 (68.00) 336 (65.24) 186 (64.36) 218 (66.87) 179 (64.62) 225 (66.57)
Ethnicity
 Hispanic/Latino 15 (15.00) 84 (16.31)   50 (17.30) 49 (15.03)   47 (16.97) 52 (15.38)  
 Not Hispanic/Latino 77 (77.00) 381 (73.98) 215 (74.39) 243 (74.54) 203 (73.29) 255 (75.44)
 Missing 8 (8.00) 50 (9.71) 24 (8.30) 34 (10.43) 27 (9.75) 31 (9.17)
Race
 White/Caucasian 53 (53.00) 301 (58.45)   169 (58.48) 185 (56.75)   163 (58.84) 191 (55.51)  
 Asian 9 (9.00) 45 (8.74)   24 (8.30) 30 (9.20)   24 (8.66) 30 (8.88)
 Black/African American 4 (4.00) 31 (6.02)   13 (4.50) 22 (6.75)   11 (3.97) 24 (7.10)
 Two or More Races 5 (5.00) 14 (2.72)   10 (3.46) 9 (2.76)   7 (2.53) 12 (3.55)
 Other/Unknownf 29 (29.00) 124 (24.08)   73 (25.26) 80 (24.54)   72 (25.99) 81 (23.96)
Marital Statusg
 Married/Domestic Partner 41 (41.00) 168 (32.62)   106 (36.68) 103 (31.60)   97 (35.02) 112 (33.14)  
 Previously Married/Previous Domestic Partner 6 (6.00) 34 (6.60) 15 (5.19) 25 (7.67) 15 (5.42) 25 (7.40)
 Single 49 (49.00) 299 (58.06) 160 (55.36) 188 (57.67) 154 (55.60) 194 (57.40)
 Otherh 4 (4.00) 14 (2.72) 8 (2.77) 10 (3.07) 11 (3.97) 7 (2.07)
Age
 Age at Baseline, Mean (SD) 39.64 (14.39) 40.67 (14.91)   40.00 (14.43) 40.95 (15.17)   39.71 (14.27) 41.15 (15.24)  
Number of Treatment Sessionsi
 Totalj, Mean (SD) 6.96 (4.02) 7.36 (4.05)   7.16 (4.04) 7.41 (4.04)   6.99 (3.94) 7.54 (4.12)  
 With a Physiciank, Mean (SD) 2.48 (2.20) 2.88 (1.98)   2.65 (2.05) 2.95 (2.00)   2.69 (2.08) 2.91 (1.97)  
 With a Therapistl, Mean (SD) 3.86 (4.38) 3.92 (4.33)   3.96 (4.43) 3.87 (4.26)   3.76 (4.36) 4.03 (4.31)  
At Risk for Other Behavioral Health Conditions
 Baseline GAD-7 Score ≥ 10 61 (61.00) 373 (72.71) * 181 (62.63) 253 (78.09) ** 200 (72.20) 234 (69.64)  
 Baseline AUDIT-C Score ≥ 3m 31 (31.00) 197 (38.48)   106 (36.81) 122 (37.65)   97 (35.14) 131 (38.99)  
 Baseline DAST-10 Score ≥ 3n 11 (11.00) 53 (10.29)   25 (8.65) 39 (11.96)   27 (9.75) 37 (10.95)  
 Baseline PCL Score > 50o 13 (13.00) 161 (31.57) ** 59 (20.56) 115 (35.60) ** 83 (30.07) 91 (27.25)  
  1. a Using 180 days (since baseline BHC) as 6-month indicator
  2. b Sample size including only patients who have at least 2 PHQ-9 scores: N = 615; PHQ-9 < 5: n = 100; PHQ-9 ≥ 5: n = 515; PHQ-9 < 10: n = 289; PHQ-9 ≥ 10: n = 326; Δ PHQ-9 ≥ 6: n = 277; Δ PHQ-9 < 6: n = 338
  3. c Percentages displayed represent “column” percentages
  4. d *p-value < 0.05, **p-value < 0.01; for continuous items, p-values represent two-sample t-test comparing mean scores between patients who have and have not reached “remission”; for categorical items, p-values represent chi-square tests under the null hypothesis of independence between “remission” status and the categorical variable
  5. e Includes any endorsement except “Not at all”
  6. f “Other/Unknown” includes: “American Indian or Alaska Native”, “Native Hawaiian or Other Pacific Islander”, “Other”, “Unknown”
  7. g Significance test
  8. h “Other” includes: Life Partner, Significant Other, Unknown, Other, Missing
  9. i Visits to BHA in the first 6 months
  10. k Includes visits that did not indicate a provider type
  11. l Includes: Physician, Fellow
  12. m Includes: Therapist, Social Worker, Care Coordinator
  13. n Clinical cutoff is ≥3 for females, ≥ 4 for males; patients were only administered the full AUDIT-C if they did not select “never” on the first item of the AUDIT-C
  14. o Cutoff ≥3 indicates at least “moderate” symptoms; patients were only administered the DAST-10 if they screened positive on the 1-item screener
  15. p Patients were only administered the PCL if they did not select “no” for more than one item on the PC-PTSD screen